Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

More Than 20 Alpha Therapies Are In Clinical Trials Says KUICK RESEARCH In Recent PublicationDelhi, Jan. 29, 2025 (GLOBE ...

Scientists say identification of two epigenetically different states in mouse model opens door to "entirely new world of ...

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic ...

Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company with a market capitalization of $9.4 billion focused on developing and commercializing novel therapies for cancer treatment, stands at a ...

The updated timeline is that Augusta Oncology will open next month in North Augusta with Beacon Bluff property to follow.

Learn more about whether Integra LifeSciences Holdings Corporation or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...

A test for pee-based markers of prostate cancer has previously relied on an uncomfortable first step. A new study has ...

Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this ...